Presne C, Fakhouri F, Kenouch S, Stengel B, Kreis H, Grünfeld J P
Service de Néphrologie adulte, Hôpital Necker, 161 rue de sèvres, 75743 Paris.
Presse Med. 2002 May 25;31(18):828-33.
Study the renal consequences of lithium therapy and find out whether lithium-induced chronic renal toxicity can provoke a progressive nephropathy, leading to advanced renal failure, requiring periodical dialysis.
Fifty-three patients treated with long-term lithium salts were included in the study. They had developed chronic renal failure (creatinine clearance inferior to 80 ml/min) not due to any other cause.
These patients had received lithium salts for a mean period of 17.7 years. The mean reduction in creatinine clearance was of 2.23 ml/min/year. Final clearance correlated negatively with the duration of lithium administration. In 7 patients treated a mean of 22 years, progression towards terminal kidney failure required periodical dialysis. Around 30% of patients exhibited mild hypercalcemia.
Lithium nephropathy inducing progressive renal failure is a reality. Its prevalence in patients treated long-term with lithium should be assessed.
研究锂盐治疗的肾脏后果,并查明锂诱导的慢性肾毒性是否会引发进行性肾病,导致晚期肾衰竭,需要定期透析。
本研究纳入了53例长期接受锂盐治疗的患者。他们出现了慢性肾衰竭(肌酐清除率低于80 ml/分钟),且并非由任何其他原因所致。
这些患者接受锂盐治疗的平均时间为17.7年。肌酐清除率的平均下降幅度为每年2.23 ml/分钟。最终清除率与锂盐给药时间呈负相关。在平均接受治疗22年的7例患者中,进展至终末期肾衰竭需要定期透析。约30%的患者出现轻度高钙血症。
锂诱导的肾病导致进行性肾衰竭是事实。应评估其在长期接受锂治疗患者中的患病率。